SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011074
Filing Date
2024-08-06
Accepted
2024-08-06 16:01:40
Documents
78
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20240630x10q.htm   iXBRL 10-Q 2602308
2 EX-3.1 kala-20240630xex3d1.htm EX-3.1 357910
3 EX-31.1 kala-20240630xex31d1.htm EX-31.1 15192
4 EX-31.2 kala-20240630xex31d2.htm EX-31.2 15178
5 EX-32.1 kala-20240630xex32d1.htm EX-32.1 6698
6 EX-32.2 kala-20240630xex32d2.htm EX-32.2 6830
  Complete submission text file 0001558370-24-011074.txt   9367395

Data Files

Seq Description Document Type Size
7 EX-101.SCH kala-20240630.xsd EX-101.SCH 66241
8 EX-101.CAL kala-20240630_cal.xml EX-101.CAL 54635
9 EX-101.DEF kala-20240630_def.xml EX-101.DEF 283840
10 EX-101.LAB kala-20240630_lab.xml EX-101.LAB 537519
11 EX-101.PRE kala-20240630_pre.xml EX-101.PRE 406049
81 EXTRACTED XBRL INSTANCE DOCUMENT kala-20240630x10q_htm.xml XML 1331354
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 241178983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)